JP2020531488A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020531488A5 JP2020531488A5 JP2020510114A JP2020510114A JP2020531488A5 JP 2020531488 A5 JP2020531488 A5 JP 2020531488A5 JP 2020510114 A JP2020510114 A JP 2020510114A JP 2020510114 A JP2020510114 A JP 2020510114A JP 2020531488 A5 JP2020531488 A5 JP 2020531488A5
- Authority
- JP
- Japan
- Prior art keywords
- trifluoromethyl
- pyridyl
- alkyl
- pharmaceutically acceptable
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CN1*C*CC1 Chemical compound CN1*C*CC1 0.000 description 7
- PVOMDMLETFHJKN-UHFFFAOYSA-N Cc1ccncc1C(F)(F)F Chemical compound Cc1ccncc1C(F)(F)F PVOMDMLETFHJKN-UHFFFAOYSA-N 0.000 description 2
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022199375A JP2023021316A (ja) | 2017-08-23 | 2022-12-14 | ピリジンアミン－ピリドンおよびピリミジンアミン－ピリドン化合物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17187560.2 | 2017-08-23 | ||
| EP17187560 | 2017-08-23 | ||
| PCT/EP2018/072790 WO2019038389A1 (en) | 2017-08-23 | 2018-08-23 | PYRIDINAMINE-PYRIDONE AND PYRIMIDINAMINE-PYRIDONE COMPOUNDS |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022199375A Division JP2023021316A (ja) | 2017-08-23 | 2022-12-14 | ピリジンアミン－ピリドンおよびピリミジンアミン－ピリドン化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020531488A JP2020531488A (ja) | 2020-11-05 |
| JP2020531488A5 true JP2020531488A5 (https=) | 2021-09-30 |
| JP7201260B2 JP7201260B2 (ja) | 2023-01-10 |
Family
ID=59686885
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020510114A Active JP7201260B2 (ja) | 2017-08-23 | 2018-08-23 | ピリジンアミン－ピリドンおよびピリミジンアミン－ピリドン化合物 |
| JP2022199375A Ceased JP2023021316A (ja) | 2017-08-23 | 2022-12-14 | ピリジンアミン－ピリドンおよびピリミジンアミン－ピリドン化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022199375A Ceased JP2023021316A (ja) | 2017-08-23 | 2022-12-14 | ピリジンアミン－ピリドンおよびピリミジンアミン－ピリドン化合物 |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US11208423B2 (https=) |
| EP (2) | EP3672948B1 (https=) |
| JP (2) | JP7201260B2 (https=) |
| KR (1) | KR102730753B1 (https=) |
| CN (3) | CN116041321A (https=) |
| AU (2) | AU2018320418B2 (https=) |
| CY (1) | CY1125728T1 (https=) |
| DK (1) | DK3672948T3 (https=) |
| ES (1) | ES2929424T3 (https=) |
| FI (1) | FI3672948T3 (https=) |
| HR (1) | HRP20221454T1 (https=) |
| HU (1) | HUE060805T2 (https=) |
| IL (3) | IL292488B2 (https=) |
| LT (1) | LT3672948T (https=) |
| PL (1) | PL3672948T3 (https=) |
| PT (1) | PT3672948T (https=) |
| RS (1) | RS63795B1 (https=) |
| SI (1) | SI3672948T1 (https=) |
| SM (1) | SMT202200493T1 (https=) |
| TW (2) | TW202325302A (https=) |
| WO (1) | WO2019038389A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202325302A (zh) * | 2017-08-23 | 2023-07-01 | 瑞典商斯普林特生物科技公司 | 吡啶胺-吡啶酮及嘧啶胺-吡啶酮化合物 |
| US11919902B2 (en) | 2017-12-22 | 2024-03-05 | Hibercell, Inc. | Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitors |
| JP7727627B2 (ja) * | 2019-12-04 | 2025-08-21 | シーエイチディーアイ ファウンデーション，インコーポレーテッド | Ａｔｍキナーゼ阻害剤及び組成物並びにそれらの使用の方法 |
| CA3199999A1 (en) | 2020-11-25 | 2022-06-02 | Deciphera Pharmaceuticals, Llc | Morpholino derivatives as vsp34 inhibitors for use in the treatment of a viral infection |
| CA3200031A1 (en) * | 2020-11-25 | 2022-06-02 | Deciphera Pharmaceuticals, Llc | Anti-viral activity of vps34 inhibitors |
| CN117241829A (zh) * | 2020-11-25 | 2023-12-15 | 德西费拉制药有限责任公司 | Vps34抑制剂的抗病毒活性 |
| CA3173777A1 (en) * | 2021-05-20 | 2022-11-20 | Dana-Farber Cancer Institute, Inc. | Inhibitors and degraders of pip4k protein |
| WO2023019259A1 (en) * | 2021-08-13 | 2023-02-16 | Deciphera Pharmaceuticals, Llc | Combination therapy of vps34 inhibitors and sting agonist for use in the treatment of cancer |
| CA3257285A1 (en) * | 2022-04-22 | 2023-10-26 | Vertex Pharmaceuticals Incorporated | HETEROARYL COMPOUNDS FOR PAIN RELIEF |
| TW202542128A (zh) * | 2023-12-13 | 2025-11-01 | 美商迪賽孚爾製藥有限公司 | Ｖｐｓ３４抑制劑及其使用方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4606161B2 (ja) * | 2002-05-21 | 2011-01-05 | アムジエン・インコーポレーテツド | 置換複素環式化合物および使用方法 |
| WO2012085815A1 (en) | 2010-12-21 | 2012-06-28 | Novartis Ag | Bi-heteroaryl compounds as vps34 inhibitors |
| DK2655375T3 (en) | 2010-12-23 | 2015-03-09 | Sanofi Sa | PYRIMIDINON DERIVATIVES, PREPARATION AND PHARMACEUTICAL USE THEREOF |
| GB201120317D0 (en) | 2011-11-24 | 2012-01-04 | Queen Mary & Westfield College | Screening method |
| FR2992314B1 (fr) | 2012-06-22 | 2015-10-16 | Sanofi Sa | Nouveaux derives de 2,3-dihydro-1h-imidazo{1,2-a}pyrimidin-5-one et 1,2,3,4-tetrahydro-pyrimido{1,2-a}pyrimidin-6-one comportant une morpholine substituee, leur preparation et leur utilisation pharmaceutique |
| WO2015108881A1 (en) | 2014-01-14 | 2015-07-23 | Millennium Pharmaceuticals, Inc. | Heteroaryls and uses thereof |
| WO2015108861A1 (en) * | 2014-01-14 | 2015-07-23 | Millennium Pharmaceuticals, Inc. | Heteroaryls and uses thereof |
| MA39822A (fr) | 2014-04-03 | 2018-02-06 | Janssen Pharmaceutica Nv | Dérivés de pyrimidine bicycle |
| MA39823A (fr) | 2014-04-03 | 2018-01-09 | Janssen Pharmaceutica Nv | Dérivés de pyridine macrocyclique |
| WO2016001789A1 (en) * | 2014-06-30 | 2016-01-07 | Pfizer Inc. | Pyrimidine derivatives as pi3k inhibitors for use in the treatment of cancer |
| TWI721104B (zh) | 2016-02-19 | 2021-03-11 | 瑞典商斯普林特生物科技公司 | 6‐芳基或6‐雜芳基‐4‐嗎啉‐4‐芳基‐吡啶‐2‐酮化合物 |
| ES2821400T3 (es) | 2016-02-19 | 2021-04-26 | Sprint Bioscience Ab | Compuestos de 6-heterociclil-4-morfolin-4-ilpiridin-2-ona útiles para el tratamiento del cáncer y la diabetes |
| TW202325302A (zh) * | 2017-08-23 | 2023-07-01 | 瑞典商斯普林特生物科技公司 | 吡啶胺-吡啶酮及嘧啶胺-吡啶酮化合物 |
-
2018
- 2018-08-23 TW TW111140666A patent/TW202325302A/zh unknown
- 2018-08-23 EP EP18759610.1A patent/EP3672948B1/en active Active
- 2018-08-23 SI SI201830781T patent/SI3672948T1/sl unknown
- 2018-08-23 HR HRP20221454TT patent/HRP20221454T1/hr unknown
- 2018-08-23 JP JP2020510114A patent/JP7201260B2/ja active Active
- 2018-08-23 LT LTEPPCT/EP2018/072790T patent/LT3672948T/lt unknown
- 2018-08-23 TW TW107129494A patent/TWI785102B/zh not_active IP Right Cessation
- 2018-08-23 AU AU2018320418A patent/AU2018320418B2/en not_active Ceased
- 2018-08-23 WO PCT/EP2018/072790 patent/WO2019038389A1/en not_active Ceased
- 2018-08-23 RS RS20221114A patent/RS63795B1/sr unknown
- 2018-08-23 FI FIEP18759610.1T patent/FI3672948T3/fi active
- 2018-08-23 PL PL18759610.1T patent/PL3672948T3/pl unknown
- 2018-08-23 ES ES18759610T patent/ES2929424T3/es active Active
- 2018-08-23 CN CN202310137693.8A patent/CN116041321A/zh active Pending
- 2018-08-23 KR KR1020207007544A patent/KR102730753B1/ko active Active
- 2018-08-23 SM SM20220493T patent/SMT202200493T1/it unknown
- 2018-08-23 DK DK18759610.1T patent/DK3672948T3/da active
- 2018-08-23 IL IL292488A patent/IL292488B2/en unknown
- 2018-08-23 US US16/639,900 patent/US11208423B2/en active Active
- 2018-08-23 IL IL302293A patent/IL302293A/en unknown
- 2018-08-23 CN CN201880060298.1A patent/CN111094271B/zh active Active
- 2018-08-23 PT PT187596101T patent/PT3672948T/pt unknown
- 2018-08-23 CN CN202310112015.6A patent/CN116041320A/zh active Pending
- 2018-08-23 HU HUE18759610A patent/HUE060805T2/hu unknown
- 2018-08-23 EP EP22199439.5A patent/EP4169581A1/en not_active Withdrawn
-
2020
- 2020-02-20 IL IL272808A patent/IL272808B/en unknown
-
2021
- 2021-11-18 US US17/530,119 patent/US11780858B2/en active Active
-
2022
- 2022-12-14 JP JP2022199375A patent/JP2023021316A/ja not_active Ceased
- 2022-12-29 CY CY20221100816T patent/CY1125728T1/el unknown
-
2023
- 2023-07-06 AU AU2023204378A patent/AU2023204378A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020531488A5 (https=) | ||
| HRP20221454T1 (hr) | Piridinamin-piridonski i pirimidinamin-piridonski spojevi | |
| JP2006509715A5 (https=) | ||
| KR101985984B1 (ko) | 키나아제 저해제로서의 벤조니트릴 유도체 | |
| RU2018131766A (ru) | 6-гетероциклил-4-морфолин-4-илпиридин-2-оны, пригодные для лечения рака и диабета | |
| JP2019505595A5 (https=) | ||
| JP2012525395A5 (https=) | ||
| JP2017502940A5 (https=) | ||
| CA2605854A1 (en) | Novel pyridine derivative and pyrimidine derivative (3) | |
| JP2017525757A5 (https=) | ||
| JP2017521407A5 (https=) | ||
| RU2015100942A (ru) | Производное пиперидинилпиразолпиридина | |
| JP2023021316A5 (https=) | ||
| JP2002525358A5 (https=) | ||
| RU2005108999A (ru) | Азотсодержащие ароматические производные | |
| RU2018131775A (ru) | 6-арил-4-морфолин-1-илпиридоны, пригодные для лечения рака или диабета | |
| RU2009104340A (ru) | Производные [4,5']бипиримидинил-6,4'-диамина в качестве ингибиторов протеинкиназы | |
| TW200526628A (en) | Quinazoline derivatives | |
| JP2019505594A5 (https=) | ||
| RU2007106042A (ru) | Замещенные биарильные аналоги пиперазинилпиридина | |
| JP2017512184A5 (https=) | ||
| JP2017536342A5 (https=) | ||
| IL274198B2 (en) | Use of Nox inhibitors to treat cancer | |
| JP2020503302A5 (https=) | ||
| JP2020531487A5 (https=) |